| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/25/2007 | EP1776340A1 N-(1h-indolyl)-h-indole-2-carb0xamide derivatives, their preparation and their therapeutic use |
| 04/25/2007 | EP1776338A1 Indole, indazole or indoline derivatives |
| 04/25/2007 | EP1776337A2 Benzyloxy derivatives as maob inhibitors |
| 04/25/2007 | EP1776336A2 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| 04/25/2007 | EP1776160A1 Novel serotonin receptor ligands and their uses thereof |
| 04/25/2007 | EP1776136A2 Treatment of conditions involving demyelination |
| 04/25/2007 | EP1776128A1 Compositions for topical treatment |
| 04/25/2007 | EP1776124A1 Immune modulating oligonucleotides in connection with chemotherapeutic measures |
| 04/25/2007 | EP1776123A1 Risedronate compositions and their methods of use |
| 04/25/2007 | EP1776122A1 Use of non-glucocorticoid steroids for the treatment of muscular dystrophy |
| 04/25/2007 | EP1776121A2 Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists |
| 04/25/2007 | EP1776120A1 Novel uses of 2-phenyl-substituted imidazotriazinone derivatives |
| 04/25/2007 | EP1776119A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 04/25/2007 | EP1776118A2 Iron chelators for treating radiocontrast-associated renal dysfunction |
| 04/25/2007 | EP1776117A1 Dual nk1/nk3 antagonists against schizophrenia |
| 04/25/2007 | EP1776116A1 Veterinary composition comprising an arylpyrazole and a nitroenamine with enhanced antiparasitic activity |
| 04/25/2007 | EP1776115A2 Use of organic compounds |
| 04/25/2007 | EP1776114A1 Combinations of gaboxadol and 5ht2a antagonists |
| 04/25/2007 | EP1776113A1 Pharmaceutical formulation based on antibiotic in microcapsule form |
| 04/25/2007 | EP1776111A2 Modulators of ppar and methods of their preparation |
| 04/25/2007 | EP1776110A1 Inhibitors of hsp90 |
| 04/25/2007 | EP1776109A1 Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid |
| 04/25/2007 | EP1776108A1 Enoximone formulations and their use in the treatment of pde-iii mediated diseases |
| 04/25/2007 | EP1776107A1 Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 04/25/2007 | EP1776106A1 Heterocyclic derivatives for modulation of calcium channels |
| 04/25/2007 | EP1776105A2 Methods and compositions for inducing innate immune responses |
| 04/25/2007 | EP1776104A1 Use of targeted oxidative therapeutic formulation in endodontic treatment |
| 04/25/2007 | EP1776103A1 Ruthenium complexes for treating cancers |
| 04/25/2007 | EP1776102A1 Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation |
| 04/25/2007 | EP1776101A1 Vaginal health products |
| 04/25/2007 | EP1776100A2 Treatment of cancer using benzoic acid derivatives |
| 04/25/2007 | EP1776099A1 Methods for improving bioavailability of a renin inhibitor |
| 04/25/2007 | EP1776098A1 Trans-clomiphene for the treatment of benign prostate hypertrophy, prostate cancer, hypogonadism, elevated triglycerides and high cholesterol |
| 04/25/2007 | EP1776097A1 Methods of treating ophthalmic conditions |
| 04/25/2007 | EP1776096A2 Crp lowering agent |
| 04/25/2007 | EP1776095A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists |
| 04/25/2007 | EP1776093A1 Compositions containing nicorandil, preparation method and use |
| 04/25/2007 | EP1776090A1 Stabilised prostaglandin composition |
| 04/25/2007 | EP1776089A2 Donepezil formulations |
| 04/25/2007 | EP1699795B1 Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives |
| 04/25/2007 | EP1697371B1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 04/25/2007 | EP1697370B1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 04/25/2007 | EP1675593A4 Process for making sterile aripiprazole of desired mean particle size |
| 04/25/2007 | EP1644482B1 Novel galactooligosaccharide composition and the preparation thereof |
| 04/25/2007 | EP1631296B1 2,3,4,5-tetrahydrobenzo¬f|¬1,4|oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease |
| 04/25/2007 | EP1599233B1 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 04/25/2007 | EP1543010B1 N-substituted hydromorphones and the use thereof |
| 04/25/2007 | EP1539183A4 Therapeutic treatment methods |
| 04/25/2007 | EP1539147A4 Methods of treating microbial infections in humans and animals |
| 04/25/2007 | EP1539135B1 Treatment of dyskinesia |
| 04/25/2007 | EP1537100B1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 04/25/2007 | EP1536845B1 Wound dressing materials comprising complexes of anionic polysaccharides with silver |
| 04/25/2007 | EP1520003B1 Process for recovery of plant sterols from by-product of vegetable oil refining |
| 04/25/2007 | EP1499184A4 Methods and compositions for treating ectoparasite infestation |
| 04/25/2007 | EP1487834B1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor |
| 04/25/2007 | EP1476192B1 Methods and compositions for treating hyperproliferative conditions |
| 04/25/2007 | EP1421120B1 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander |
| 04/25/2007 | EP1420789B1 USE OF ACTIVE INGREDIENTS HAVING A µ-OPIOID RECEPTOR AGONIST ACTION AND AN OPIOID RECEPTOR ANTAGONIST ACTION, AS COMBINATION DRUGS FOR THE TREATMENT OF CANCER |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1392335B1 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite |
| 04/25/2007 | EP1369122B1 Anticancer agent |
| 04/25/2007 | EP1359919B1 Use of quetiapine for the treatment of cocaine dependence |
| 04/25/2007 | EP1326623B1 Saururus chinensis extract for prevention and treatment of neurodegenerative disease |
| 04/25/2007 | EP1315710B1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1305037B1 Analgesic medicament |
| 04/25/2007 | EP1259813B1 Diagnosis of malignant neoplasms |
| 04/25/2007 | EP1254174B1 Human cyr61 |
| 04/25/2007 | EP1210336B1 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 04/25/2007 | EP1209151B1 4-substituted piperidine derivatives |
| 04/25/2007 | EP1200824B1 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives |
| 04/25/2007 | EP1142586B1 Use of chymase inhibitors against vascular lipid deposition |
| 04/25/2007 | EP1128833B1 Use of agonists of corticosteroid receptors and a drug to treat addiction |
| 04/25/2007 | EP1104417B1 Improved omeprazole process and compositions thereof |
| 04/25/2007 | EP1100780B1 2,3,3a,4,9,9a-HEXAHYDRO-8-HYDROXY-1H-BENZ[F]INDOLES, A METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE AS MEDICAMENTS |
| 04/25/2007 | EP1049468B1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers |
| 04/25/2007 | EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 04/25/2007 | EP1024138B1 Pyrazole derivatives |
| 04/25/2007 | EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953985A Prodrugs of piperazine and substituted piperidine antiviral agents |
| 04/25/2007 | CN1953983A 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
| 04/25/2007 | CN1953982A 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
| 04/25/2007 | CN1953979A Substituted 5,12-diaza-benzoanthracene analogues |
| 04/25/2007 | CN1953978A 5-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b] indol-2-ones and analogs as anti-virals |
| 04/25/2007 | CN1953977A Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof |
| 04/25/2007 | CN1953976A Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain |
| 04/25/2007 | CN1953975A 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 04/25/2007 | CN1953974A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 04/25/2007 | CN1953973A Preparation of candesartan cilexetil in high purity |
| 04/25/2007 | CN1953972A 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 04/25/2007 | CN1953971A Derivatives of dihydronepetalactone and method for preparation |
| 04/25/2007 | CN1953968A Thiazole compound and use thereof |
| 04/25/2007 | CN1953967A Purification of progesterone receptor modulators |
| 04/25/2007 | CN1953966A Anticancer agent |
| 04/25/2007 | CN1953965A Novel cis-imidazolines |
| 04/25/2007 | CN1953964A Resistance-repellent retroviral protease inhibitors |
| 04/25/2007 | CN1953961A Method for producing 1,4-diphenyl azetidinone derivatives |
| 04/25/2007 | CN1953784A Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms |